Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology

Targeted Sensitization of Glioblastoma Multiforme Using AAAPT Technology 150 150 IEEE Open Journal of Engineering in Medicine and Biology (OJEMB)

Abstract:

Glioblastoma Multiforme (GBM) is the most malignant type of all brain tumors. Current GBM treatment options include surgery, followed by radiation and chemotherapy. However, GBM can become resistant to therapy, resulting in tumor recurrence. GBM cells develop resistance to treatments by either downregulating cell death pathways (CD95) or upregulating cell …

View on IEEE Xplore